Operating Partner · PE-Backed SaaS & Tech

Building Operational Alpha
for the AI Era.

I help Growth and Buyout funds turn "Value Drifters" into "Value Catalysts." I've operated a scale-up to €240M ARR. I know exactly what awaits your portfolio companies between €10M and €100M ARR.

Request a Diagnostic Why Akovance
€240M
ARR Operated
107%
NRR Achieved
$40M
Portfolio Managed
3–4
Funds Per Year

The Problem

Strategy Without Execution Muscle

Many SaaS companies in the €10M–€150M range suffer from "Value Drift": burning resources, stalled growth, and friction-heavy engines. Strategy alone isn't enough for the 2026 execution cycle. They need an Execution Reboot.

"Big company" playbooks fail when copy-pasted into this high-growth stage. The operators who have lived it — and know where the bodies are buried — are the ones who can unlock real shareholder value.

Burning Resources

GTM spend leaking through an undefined ICP and misaligned sales motion.

Stalled Growth

NRR decaying while churn goes unmeasured and adoption remains low.

Friction-Heavy Engine

Manual, gut-feel decisions replacing the data-driven operating cadence that scale demands.

The Solution

A Dedicated Operating Partner

I provide the "Operating Muscle" required to activate AI-driven commercial motions and GTM transformations — embedded alongside your portfolio company's leadership team.

01

GTM Transformation

Redefining ICP and sales motions for the €10M–€150M ARR range — where generic playbooks go to die.

02

AI-Enabled Motions

Predictive churn scoring, AI-assisted QBRs, and data-driven decision making embedded into daily operations.

03

Outcome-Based Growth

Scaling NRR through adoption-led growth and value realization — turning customers into an expansion engine.

Work With Me

The "Proof-of-Value" Diagnostic

I don't believe in long, theoretical consulting cycles. I start with a ruthlessly targeted audit to find exactly where you are leaving money on the table.

1

Selection

We identify the one company in your portfolio that worries you most regarding value creation.

2

The Deep Dive

I spend one full day with the CEO, CRO, and CFO auditing their core metrics and GTM engine.

3

The 5-Page Memo

You receive a concise blueprint with immediate, actionable clarity for your portfolio.

What You Receive

3 Red Flags — Critical execution gaps identified in the audit.
Quantified Value Leakage — The exact Euro amount left on the table, calculated.
The 100-Day Plan — A structured roadmap to capture that value, starting immediately.

My Guarantee: If this diagnostic does not provide immediate shareholder clarity, it's on me. If it's useful, we discuss a structured long-term engagement.

Why Akovance

Operator-Grade Expertise. No Exceptions.

I know exactly what awaits your portfolio companies between €10M and €100M ARR — and more importantly, I know why "big company" playbooks fail when copy-pasted into this stage.

🏛

Vista Equity Heritage

A decade of embedded work alongside Vista Equity Partners, managing a $40M ARR portfolio to 107% NRR.

🌐

Global Scale

Built and scaled a global Business Value Consulting function from zero across North America, EMEA, and APAC.

📈

Growth Fund Expertise

Specialized GTM work for Growth funds including Iris, Eurazeo, and Highland Capital Partners.

⚙️

Mid-Cap Tech Buyout

Deep experience with top-tier European buyout sponsors: Apax, PAI Partners, and Ardian.

Limited Availability

Only 3–4 Funds Per Year.
By Design.

To guarantee the quality and "operating muscle" I bring to each partner, I only launch with 3–4 funds per year.

Slots Filled
2 of 4
In Progress
1 Diagnostic
Open
1 Slot

Currently booking diagnostic windows. If you have a portfolio company that needs an execution reboot, let's talk.

Contact Grigor Kotzev